Impact of prior irregular infliximab dos
โ
Daniel J. Stein; Ashwin N. Ananthakrishnan; Mazen Issa; John B. Williams; Dawn B
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 285 KB
๐ 2 views
## Background: Infliximab is efficacious in the management of moderate to severe crohn's disease (cd). there are limited data regarding performance of infliximab in patients who require reinitiation of maintenance dosing following previous irregular exposure. ## Methods: This was a retrospective,